|
CUSIP NO. |
555903301 |
13G |
Page 1 of 16 |
|
UNITED STATES |
|
SECURITIES AND EXCHANGE COMMISSION |
|
Washington, D.C. 20549 |
|
SCHEDULE 13G |
|
Under the Securities Exchange Act of 1934 |
|
(Amendment No. 1)* |
|
MACROCHEM CORPORATION |
|
(Name of Issuer) |
|
Common Stock, $.01 par value |
|
(Title of Class of Securities) |
|
555903301 |
|
(CUSIP Number) |
|
August 31, 2008 |
|
(Date of Event Which Requires Filing of this Statement) |
|
Check the appropriate box to designate the rule pursuant to which this |
|
Schedule is filed: |
|
x |
Rule 13d-1(b) |
|
o |
Rule 13d-1(c) |
|
o |
Rule 13d-1(d) |
|
*The remainder of this cover page shall be filled out for a reporting person's |
|
initial filing on this form with respect to the subject class of securities, |
|
and for any subsequent amendment containing information which would alter the |
|
disclosures provided in a prior cover page. |
|
The information required in the remainder of this cover page shall not be |
|
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange |
|
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of |
|
the Act but shall be subject to all other provisions of the Act (however, see |
|
the Notes). |
|
CUSIP NO. |
555903301 |
13G |
Page 2 of 16 |
|
1. |
NAMES OF REPORTING PERSONS. |
|
Franklin Resources, Inc. |
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
|
(a) |
|
(b) |
X |
|
3. |
SEC USE ONLY |
|
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
Delaware |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
|
5. |
SOLE VOTING POWER |
|
(See Item 4) |
|
6. |
SHARED VOTING POWER |
|
(See Item 4) |
|
7. |
SOLE DISPOSITIVE POWER |
|
(See Item 4) |
|
8. |
SHARED DISPOSITIVE POWER |
|
(See Item 4) |
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
3,222,5001 |
|
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
CERTAIN SHARES o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
6.9% |
|
12. |
TYPE OF REPORTING PERSON |
|
HC, CO (See Item 4) |
|
CUSIP NO. |
555903301 |
13G |
Page 3 of 16 |
|
1. |
NAMES OF REPORTING PERSONS. |
|
Charles B. Johnson |
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
|
(a) |
|
(b) |
X |
|
3. |
SEC USE ONLY |
|
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
USA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
|
5. |
SOLE VOTING POWER |
|
(See Item 4) |
|
6. |
SHARED VOTING POWER |
|
(See Item 4) |
|
7. |
SOLE DISPOSITIVE POWER |
|
(See Item 4) |
|
8. |
SHARED DISPOSITIVE POWER |
|
(See Item 4) |
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
3,222,500 |
|
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
CERTAIN SHARES o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
6.9% |
|
12. |
TYPE OF REPORTING PERSON |
|
HC, IN (See Item 4) |
|
CUSIP NO. |
555903301 |
13G |
Page 4 of 16 |
|
1. |
NAMES OF REPORTING PERSONS. |
|
Rupert H. Johnson, Jr. |
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
|
(a) |
|
(b) |
X |
|
3. |
SEC USE ONLY |
|
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
USA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
|
5. |
SOLE VOTING POWER |
|
(See Item 4) |
|
6. |
SHARED VOTING POWER |
|
(See Item 4) |
|
7. |
SOLE DISPOSITIVE POWER |
|
(See Item 4) |
|
8. |
SHARED DISPOSITIVE POWER |
|
(See Item 4) |
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
3,222,500 |
|
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
CERTAIN SHARES o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
6.9% |
|
12. |
TYPE OF REPORTING PERSON |
|
HC, IN (See Item 4) |
|
CUSIP NO. |
555903301 |
13G |
Page 5 of 16 |
|
1. |
NAMES OF REPORTING PERSONS. |
|
Franklin Advisers, Inc. |
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
|
(a) |
|
(b) |
X |
|
3. |
SEC USE ONLY |
|
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
California |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
|
5. |
SOLE VOTING POWER |
|
3,222,500 |
|
6. |
SHARED VOTING POWER |
|
0 |
|
7. |
SOLE DISPOSITIVE POWER |
|
3,222,500 |
|
8. |
SHARED DISPOSITIVE POWER |
|
0 |
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
3,222,500 |
|
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
CERTAIN SHARES o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
6.9% |
|
12. |
TYPE OF REPORTING PERSON |
|
IA, CO (See Item 4) |
|
CUSIP NO. |
555903301 |
13G |
Page 6 of 16 |
|
Item 1. |
|
(a) |
Name of Issuer |
|
MACROCHEM CORPORATION |
|
(b) |
Address of Issuer's Principal Executive Offices |
|
80 Broad Street, 22nd Floor |
|
New York, NY 10004 |
|
Item 2. |
|
(a) |
Name of Person Filing |
|
(i): |
Franklin Resources, Inc. |
|
(ii): |
Charles B. Johnson |
|
(iii): |
Rupert H. Johnson, Jr. |
|
(iv): |
Franklin Advisers, Inc. |
|
(b) |
Address of Principal Business Office or, if none, Residence |
|
(i), (ii), and (iii): |
|
One Franklin Parkway |
|
San Mateo, CA 94403-1906 |
|
(iv): |
One Franklin Parkway |
|
San Mateo, CA 94403-1906 |
|
(c) |
Citizenship |
|
(i): |
Delaware |
|
(ii) and (iii): USA |
|
(iv): |
California |
|
(d) |
Title of Class of Securities |
|
Common Stock, $.01 par value |
|
(e) |
CUSIP Number |
|
555903301 |
|
CUSIP NO. |
555903301 |
13G |
Page 7 of 16 |
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or |
|
(c), check whether the person filing is a: |
|
(a) |
o Broker or dealer registered under section 15 of the Act |
|
(15 U.S.C. 78o). |
|
(b) |
o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
|
(c) |
o Insurance company as defined in section 3(a)(19) of the |
|
Act (15 U.S.C. 78c). |
|
(d) |
o Investment company registered under section 8 of the |
|
Investment Company Act of 1940 (15 U.S.C 80a-8). |
|
(e) |
x An investment adviser in accordance with §240.13d-1(b)(1) |
|
(ii)(E); |
|
(f) |
o An employee benefit plan or endowment fund in accordance |
|
with §240.13d-1(b)(1)(ii)(F); |
|
(g) |
x A parent holding company or control person in accordance |
|
with §240.13d-1(b)(1)(ii)(G); |
|
(h) |
o A savings associations as defined in Section 3(b) of the |
|
Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
(i) |
o A church plan that is excluded from the definition of an |
|
investment company under section 3(c)(14) of the Investment |
|
Company Act of 1940 (15 U.S.C. 80a-3); |
|
(j) |
o Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
|
Item 4. |
Ownership |
|
The securities reported herein (the Securities) are beneficially owned by one |
|
or more open- or closed-end investment companies or other managed accounts that |
|
are investment management clients of investment managers that are direct and |
|
indirect subsidiaries (each, an Investment Management Subsidiary and, |
|
collectively, the Investment Management Subsidiaries) of Franklin Resources, |
|
Inc. (FRI), including the Investment Management Subsidiaries listed in Item |
|
7. Investment management contracts grant to the Investment Management |
|
Subsidiaries all investment and/or voting power over the securities owned by |
|
such investment management clients, unless otherwise noted in this Item 4. |
|
Therefore, for purposes of Rule 13d-3 under the Act, the Investment Management |
|
Subsidiaries may be deemed to be the beneficial owners of the Securities. |
|
Beneficial ownership by investment management subsidiaries and other affiliates |
|
of FRI is being reported in conformity with the guidelines articulated by the |
|
SEC staff in Release No. 34-39538 (January 12, 1998) relating to organizations, |
|
such as FRI, where related entities exercise voting and investment powers over |
|
the securities being reported independently from each other. The voting and |
|
investment powers held by Franklin Mutual Advisers, LLC (FMA), an indirect |
|
wholly-owned Investment Management Subsidiary, are exercised independently from |
|
FRI and from all other Investment Management Subsidiaries (FRI, its affiliates |
|
and the Investment Management Subsidiaries other than FMA are collectively, |
|
FRI affiliates). Furthermore, internal policies and procedures of FMA and FRI |
|
establish informational barriers that prevent the flow between FMA and the FRI |
|
affiliates of information that relates to the voting and investment powers over |
|
the securities owned by their respective investment management clients. |
|
Consequently, FMA and the FRI affiliates report the securities over which they |
|
hold investment and voting power separately from each other for purposes of |
|
Section 13 of the Act. |
|
CUSIP NO. |
555903301 |
13G |
Page 8 of 16 |
|
Charles B. Johnson and Rupert H. Johnson, Jr. (the Principal Shareholders) |
|
each own in excess of 10% of the outstanding common stock of FRI and are the |
|
principal stockholders of FRI. FRI and the Principal Shareholders may be |
|
deemed to be, for purposes of Rule 13d-3 under the Act, the beneficial owners |
|
of securities held by persons and entities for whom or for which FRI |
|
subsidiaries provide investment management services. The number of shares that |
|
may be deemed to be beneficially owned and the percentage of the class of which |
|
such shares are a part are reported in Items 9 and 11 of the cover pages for |
|
FRI and each of the Principal Shareholders. FRI, the Principal Shareholders |
|
and each of the Investment Management Subsidiaries disclaim any pecuniary |
|
interest in any of the Securities. In addition, the filing of this Schedule |
|
13G on behalf of the Principal Shareholders, FRI and FRI affiliates, as |
|
applicable, should not be construed as an admission that any of them is, and |
|
each disclaims that it is, the beneficial owner, as defined in Rule 13d-3, of |
|
any of the Securities. |
|
FRI, the Principal Shareholders, and each of the Investment Management |
|
Subsidiaries believe that they are not a group within the meaning of Rule |
|
13d-5 under the Act and that they are not otherwise required to attribute to |
|
each other the beneficial ownership of the Securities held by any of them or by |
|
any persons or entities for whom or for which FRI subsidiaries provide |
|
investment management services. |
|
(a) |
Amount beneficially owned: |
|
3,222,500 |
|
(b) |
Percent of class: |
|
6.9% |
|
(c) |
Number of shares as to which the person has: |
|
(i) |
Sole power to vote or to direct the vote |
|
Franklin Resources, Inc.: |
0 |
|
Charles B. Johnson: |
0 |
|
Rupert H. Johnson, Jr.: |
0 |
|
Franklin Advisers, Inc.: |
3,222,500 |
|
(ii) |
Shared power to vote or to direct the vote |
|
0 |
|
(iii) |
Sole power to dispose or to direct the disposition of |
|
Franklin Resources, Inc.: |
0 |
|
Charles B. Johnson: |
0 |
|
Rupert H. Johnson, Jr.: |
0 |
|
Franklin Advisers, Inc.: |
3,222,500 |
|
(iv) |
Shared power to dispose or to direct the disposition of |
|
0 |
|
Item 5. |
Ownership of Five Percent or Less of a Class |
|
CUSIP NO. |
555903301 |
13G |
Page 9 of 16 |
|
If this statement is being filed to report the fact that as of the date |
|
hereof the reporting person has ceased to be the beneficial owner of |
|
more than five percent of the class of securities, |
|
check the following o. Not Applicable |
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
|
The clients of the Investment Management Subsidiaries, including investment |
|
companies registered under the Investment Company Act of 1940 and other managed |
|
accounts, have the right to receive or power to direct the receipt of dividends |
|
from, as well a |
s the proceeds from the sale of, such securities reported on in |
|
this statement. Franklin Biotechnology Discovery Fund, a series of Franklin |
|
Strategic Series, an investment company registered under the Investment Company |
|
Act of 1940, has an interest in 2,925,000 shares, or 6.3%, of the class of |
|
securities reported herein. |
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the |
|
Security Being Reported on By the Parent Holding Company |
|
See Attached Exhibit C |
|
(See also Item 4) |
|
Item 8. |
Identification and Classification of Members of the Group |
|
Not Applicable (See also Item 4) |
|
Item 9. |
Notice of Dissolution of Group |
|
Not Applicable |
|
CUSIP NO. |
555903301 |
13G |
Page 10 of 16 |
|
Item 10. |
Certification |
|
By signing below I certify that, to the best of my knowledge and belief, the |
|
securities referred to above were acquired and are held in the ordinary course |
|
of business and were not acquired and are not held for the purpose of or with |
|
the effect of changing or influencing the control of the issuer of the |
|
securities and were not acquired and are not held in connection with or as a |
|
participant in any transaction having that purpose or effect. |
|
This report shall not be construed as an admission by the persons filing the |
|
report that they are the beneficial owner of any securities covered by this |
|
report. |
|
SIGNATURE |
|
After reasonable inquiry and to the best of my knowledge and belief, I certify |
|
that the information set forth in this statement is true, complete and correct. |
|
Dated: |
September 9, 2008 |
|
Franklin Resources, Inc. |
|
Charles B. Johnson |
|
Rupert H. Johnson, Jr. |
|
By: |
/s/ROBERT C. ROSSELOT |
|
----------------------------- |
|
Robert C. Rosselot |
|
Assistant Secretary of Franklin Resources, Inc. |
|
Attorney-in-Fact for Charles B. Johnson pursuant to Power of |
|
Attorney attached to this Schedule 13G |
|
Attorney-in-Fact for Rupert H. Johnson, Jr. pursuant to Power of |
|
Attorney attached to this Schedule 13G |
|
Franklin Advisers, Inc. |
|
By: |
/s/ALISON E. BAUR |
|
--------------------------------- |
|
Alison E. Baur |
|
Secretary of Franklin Advisers, Inc. |
|
Franklin Strategic Series on behalf of |
|
Franklin Biotechnology Discovery Fund |
By: |
/s/KAREN L. SKIDMORE |
|
--------------------------------- |
|
Karen L. Skidmore |
|
Vice President & Secretary of Franklin Strategic Series |
|
CUSIP NO. |
555903301 |
13G |
Page 11 of 16 |
|
EXHIBIT A |
|
JOINT FILING AGREEMENT |
|
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as |
|
amended, the undersigned hereby agree to the joint filing with each other of |
|
the attached statement on Schedule 13G and to all amendments to such statement |
|
and that such statement and all amendments to such statement are made on behalf |
|
of each of them. |
|
IN WITNESS WHEREOF, the undersigned have executed this agreement on |
|
September 9, 2008. |
|
Franklin Resources, Inc. |
|
Charles B. Johnson |
|
Rupert H. Johnson, Jr. |
|
By: |
/s/ROBERT C. ROSSELOT |
|
----------------------------- |
|
Robert C. Rosselot |
|
Assistant Secretary of Franklin Resources, Inc. |
|
Attorney-in-Fact for Charles B. Johnson pursuant to Power of |
|
Attorney attached to this Schedule 13G |
|
Attorney-in-Fact for Rupert H. Johnson, Jr. pursuant to Power of |
|
Attorney attached to this Schedule 13G |
|
Franklin Advisers, Inc. |
|
By: |
/s/ALISON E. BAUR |
|
--------------------------------- |
|
Alison E. Baur |
|
Secretary of Franklin Advisers, Inc. |
|
Franklin Strategic Series on behalf of |
|
Franklin Biotechnology Discovery Fund |
By: |
/s/KAREN L. SKIDMORE |
|
--------------------------------- |
|
Karen L. Skidmore |
|
Vice President & Secretary of Franklin Strategic Series |
|
CUSIP NO. |
555903301 |
13G |
Page 12 of 16 |
|
EXHIBIT B |
|
LIMITED POWER OF ATTORNEY |
|
FOR |
|
SECTION 13 REPORTING OBLIGATIONS |
|
Know all by these presents, that the undersigned hereby makes, |
|
constitutes and appoints each of Robert Rosselot and Maria Gray, each acting |
|
individually, as the undersigneds true and lawful attorney-in-fact, with full |
|
power and authority as hereinafter described on behalf of and in the name, |
|
place and stead of the undersigned to: |
|
(1) |
prepare, execute, acknowledge, deliver and file Schedules 13D and 13G |
|
(including any amendments thereto or any related documentation) with the United |
|
States Securities and Exchange Commission, any national securities exchanges |
|
and Franklin Resources, Inc., a Delaware corporation (the Reporting Entity), |
|
as considered necessary or advisable under Section 13 of the Securities |
|
Exchange Act of 1934 and the rules and regulations promulgated thereunder, as |
|
amended from time to time (the Exchange Act); and |
|
(2) |
perform any and all other acts which in the discretion of such |
|
attorney-in-fact are necessary or desirable for and on behalf of the |
|
undersigned in connection with the foregoing. |
|
The undersigned acknowledges that: |
|
(1) |
this Limited Power of Attorney authorizes, but does not require, each such |
|
attorney-in-fact to act in their discretion on information provided to such |
|
attorney-in-fact without independent verification of such information; |
|
(2) |
any documents prepared and/or executed by either such attorney-in-fact on |
|
behalf of the undersigned pursuant to this Limited Power of Attorney will be in |
|
such form and will contain such information and disclosure as such |
|
attorney-in-fact, in his or her discretion, deems necessary or desirable; |
|
(3) |
neither the Reporting Entity nor either of such attorneys-in-fact assumes |
|
(i) any liability for the undersigneds responsibility to comply with the |
|
requirements of the Exchange Act or (ii) any liability of the undersigned for |
|
any failure to comply with such requirements; and |
|
(4) |
this Limited Power of Attorney does not relieve the undersigned from |
|
responsibility for compliance with the undersigneds obligations under the |
|
Exchange Act, including without limitation the reporting requirements under |
|
Section 13 of the Exchange Act. |
|
CUSIP NO. |
555903301 |
13G |
Page 13 of 16 |
|
The undersigned hereby gives and grants each of the foregoing attorneys-in-fact |
|
full power and authority to do and perform all and every act and thing |
|
whatsoever requisite, necessary or appropriate to be done in and about the |
|
foregoing matters as fully to all intents and purposes as the undersigned might |
|
or could do if present, hereby ratifying all that each such attorney-in-fact |
|
of, for and on behalf of the undersigned, shall lawfully do or cause to be done |
|
by virtue of this Limited Power of Attorney. |
|
This Limited Power of Attorney shall remain in full force and effect until |
|
revoked by the undersigned in a signed writing delivered to each such |
|
attorney-in-fact. |
|
IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney |
|
to be executed as of this |
30th |
day of |
April |
, 2007 |
|
/s/Charles B. Johnson |
|
Signature |
|
Charles B. Johnson |
|
Print Name |
|
CUSIP NO. |
555903301 |
13G |
Page 14 of 16 |
|
LIMITED POWER OF ATTORNEY |
|
FOR |
|
SECTION 13 REPORTING OBLIGATIONS |
|
Know all by these presents, that the undersigned hereby makes, |
|
constitutes and appoints each of Robert Rosselot and Maria Gray, each acting |
|
individually, as the undersigneds true and lawful attorney-in-fact, with full |
|
power and authority as hereinafter described on behalf of and in the name, |
|
place and stead of the undersigned to: |
|
(1) |
prepare, execute, acknowledge, deliver and file Schedules 13D and 13G |
|
(including any amendments thereto or any related documentation) with the United |
|
States Securities and Exchange Commission, any national securities exchanges |
|
and Franklin Resources, Inc., a Delaware corporation (the Reporting Entity), |
|
as considered necessary or advisable under Section 13 of the Securities |
|
Exchange Act of 1934 and the rules and regulations promulgated thereunder, as |
|
amended from time to time (the Exchange Act); and |
|
(2) |
perform any and all other acts which in the discretion of such |
|
attorney-in-fact are necessary or desirable for and on behalf of the |
|
undersigned in connection with the foregoing. |
|
The undersigned acknowledges that: |
|
(1) |
this Limited Power of Attorney authorizes, but does not require, each such |
|
attorney-in-fact to act in their discretion on information provided to such |
|
attorney-in-fact without independent verification of such information; |
|
(2) |
any documents prepared and/or executed by either such attorney-in-fact on |
|
behalf of the undersigned pursuant to this Limited Power of Attorney will be in |
|
such form and will contain such information and disclosure as such |
|
attorney-in-fact, in his or her discretion, deems necessary or desirable; |
|
(3) |
neither the Reporting Entity nor either of such attorneys-in-fact assumes |
|
(i) any liability for the undersigneds responsibility to comply with the |
|
requirements of the Exchange Act or (ii) any liability of the undersigned for |
|
any failure to comply with such requirements; and |
|
(4) |
this Limited Power of Attorney does not relieve the undersigned from |
|
responsibility for compliance with the undersigneds obligations under the |
|
Exchange Act, including without limitation the reporting requirements under |
|
Section 13 of the Exchange Act. |
|
CUSIP NO. |
555903301 |
13G |
Page 15 of 16 |
|
The undersigned hereby gives and grants each of the foregoing attorneys-in-fact |
|
full power and authority to do and perform all and every act and thing |
|
whatsoever requisite, necessary or appropriate to be done in and about the |
|
foregoing matters as fully to all intents and purposes as the undersigned might |
|
or could do if present, hereby ratifying all that each such attorney-in-fact |
|
of, for and on behalf of the undersigned, shall lawfully do or cause to be done |
|
by virtue of this Limited Power of Attorney. |
|
This Limited Power of Attorney shall remain in full force and effect until |
|
revoked by the undersigned in a signed writing delivered to each such |
|
attorney-in-fact. |
|
IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney |
|
to be executed as of this |
25th |
day of |
April |
, 2007 |
|
/s/ Rupert H. Johnson, Jr. |
|
Signature |
|
Rupert H. Johnson, Jr. |
|
Print Name |
|
CUSIP NO. |
555903301 |
13G |
Page 16 of 16 |
|
EXHIBIT C |
|
Franklin Advisers, Inc. |
Item 3 Classification: 3(e) |
Footnotes to Schedule 13G
_________________________
1 Includes 750,000 shares of underlying common stock purchase warrants.